Skip to content
← Recursion

Executive Director, Clinical Pharmacology/Pharmacometrics

Recursion · Remote Opportunity - United States · London, England · New York, New York · Salt Lake City, Utah

CHECKED 1H AGO

Bio & Science AIremoteexecutive$288k–$346k
Apply on the lab’s site ↗

At a glance

Highlights

  • Lead clinical pharmacology strategy for rare disease and oncology programs.
  • Drive modeling and simulation to accelerate dose selection and decisions.
  • Serve as clinical pharmacology expert for global health authority interactions.

Ideal candidate

A decisive, collaborative drug development leader with 10+ years driving clinical pharmacology strategy who thrives in fast-growing biotech and is passionate about delivering therapies to patients with devastating diseases.

Requirements

  • Ph.D. in Pharmaceutical Sciences, Pharmacokinetics or related discipline, M.D. with Clinical Pharmacology expertise, or PharmD with Clinical Pharmacology fellowship
  • 10+ years of experience in biotech/pharmaceutical drug development
  • Demonstrated success leading all clinical pharmacology aspects of drug development
  • Experience managing PK, PK-PD and PK-safety analyses including NCA, population PK and PK-PD modeling and simulation
  • Proficiency with WinNonlin, Monolix, NONMEM, R or other modeling software
  • Demonstrated experience responding to regulatory agency questions and preparing clinical pharmacology sections of submissions
  • Experience attending regulatory meetings and acting as clinical pharmacology expert
  • Experience in oncology preferred
remote policy
Remote in the United States with periodic travel required

Lab profile

About Recursion

AI-native biotech industrializing drug discovery with automation and data to advance oncology and rare disease medicines.

What they build

  • Recursion OS drug discovery platform
  • Oncology clinical pipeline
  • Rare disease clinical pipeline

Known for

  • AI-native end-to-end drug discovery
  • Computational biology for early discovery
  • Clinical development in oncology and rare disease

Key facts

  • Founded 2013
  • Headquartered in Salt Lake City, Utah
  • Public company (Nasdaq: RXRX)
More about Recursion →
Apply on the lab’s site ↗